Connect to other sites within the UBM Medica Network
Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.
Follow Her on Twitter
Chemo During Pregnancy Did Not Affect Early Child Development
Children exposed to their mother’s cancer and cancer treatment did not appear to have cardiac, cognitive, or general developmental issues up to 36 months of age.
Some Breast Cancer Patients Can Forgo Chemotherapy
Some patients with early-stage HR-positive breast cancer can be treated with hormone therapy alone, avoiding chemo without increasing their recurrence risk.
Public Awareness of Surgical Options for Breast Cancer Improves
Significantly more women are now aware of reconstructive surgery options after mastectomies for breast cancer, following coverage of Angelina Jolie’s mastectomies in 2013.
Colorectal Tumors Differ By Age
A study showed that tumors of younger patients with early-onset colorectal cancer differ from the tumors of those diagnosed later in life, both genetically and epigenetically.
Genetics of Brain Metastases Reveal Potential Drug Targets
A genomic analysis of the primary tumors and brain metastases of patients has revealed potentially targetable mutations only present in the brain metastases.
Brentuximab Vedotin Effective in Older Hodgkin Lymphoma Patients
The antibody-drug conjugate brentuximab vedotin is effective as a frontline therapy for Hodgkin lymphoma patients over age 60 who are unfit for chemotherapy.
Intermittent ADT for Prostate Cancer May Improve QoL
A new meta-analysis suggests that survival outcomes are similar with intermittent and continuous androgen deprivation therapy, and that intermittent therapy may improve some quality-of-life criteria.
Prostate Cancer Combo Therapy May Not Be One Size Fits All
Six months of radiation therapy combined with ADT for prostate cancer may not produce a survival benefit in men with moderate to severe comorbidities.
Genetics May Explain Aggressive Breast Tumors in African Americans
According to the results of a genomic analysis, several genetic characteristics linked with aggressive cancer are more common in the breast tumors of African American women compared to their white counterparts.
Survival Improvement With Transplant for Light-Chain Amyloidosis Patients
More patients with light-chain amyloidosis are surviving longer after autologous hematopoietic cell transplantation, with a reduction in early post-transplant mortality.
By clicking Accept, you agree to become a member of the UBM Medica Community.